A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy

Chemotherapy remains a primary cancer treatment. However, the poor selectivity of conventional small-molecule chemotherapeutic agents often leads severe side effects against normal cells and tissues, limiting their clinical application. To...